| GENFIT S.A. ADR/1 EO-,25 |
| USA |
| Gesundheit |
| US3722791098 / A2PFG5 |
| XUPB (Frankfurt) |
| FRA:XUPB, ETR:XUPB, XUPB:GR |
| - |
| https://www.genfit.com/ |
|
Genfit S.A. ADR represents American Depositary Receipts of Genfit, a biopharmaceutical company headquartered in France. Its primary function is to facilitate U.S. investors' access to Genfit's equities, enabling them to invest in the company's shares..
>Volltext.. |
| 445.46 Mio. EUR |
| 495.34 Mio. EUR |
| 65.82 Mio. EUR |
| -59.45 Mio. EUR |
| -86.47 Mio. EUR |
| -1.73 EUR |
| 151.57 Mio. EUR |
| 101.68 Mio. EUR |
| -25.47 Mio. EUR |
| 1.4 |
| 10.8% |
| -6572.14% |
| - |
| - |
| - |
| - |
| GENFIT ADR, GENFIT |
| 08.04.26 |
|